The potential role of amifostine in the treatment of non small cell lung cancer
- 1 July 2000
- journal article
- review article
- Published by Elsevier in Lung Cancer
- Vol. 29 (1) , 57-66
- https://doi.org/10.1016/s0169-5002(00)00100-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- CALGB Study 9431: A randomized phase II study of cisplatin with gemcitabine or paclitaxel or vinorelbine as induction chemotherapy (Ind CT) and concomitant chemoradiotherapy (XRT) for unresectable stage III non-small cell lung cancer (NSCLC)Lung Cancer, 2000
- 55: A phase III randomised study of carboplatin and amifostine (A) vs carboplatin and G-CSF in patients with inoperable non small cell lung cancer (NSCLC)European Journal Of Cancer, 1997
- Randomized trial of carboplatin plus amifostine versus carboplatin alone in patients with advanced solid tumorsCancer, 1997
- Intensive radiochemotherapy (RCT) with amifostine (A) in head and neck (H&N) cancerEuropean Journal Of Cancer, 1997
- Hypotensive Mechanisms of AmifostineThe Journal of Clinical Pharmacology, 1996
- AmifostineDrugs, 1995
- Use of radiation with or without WR-2721 in advanced rectal cancerCancer, 1992
- Hypocalcemia and Inhibition of Parathyroid Hormone Secretion after Administration of WR-2721 (a Radioprotective and Chemoprotective Agent)New England Journal of Medicine, 1983
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977
- Localized Areas of High Alkaline Phosphatase Activity in Endothelium of ArteriesNature, 1962